Jennison Associates
BSX icon

Jennison Associates’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$227M Buy
2,115,002
+1,186,949
+128% +$127M 0.13% 75
2025
Q1
$93.6M Sell
928,053
-1,014,902
-52% -$102M 0.07% 136
2024
Q4
$174M Buy
1,942,955
+414,774
+27% +$37M 0.11% 91
2024
Q3
$128M Sell
1,528,181
-511,463
-25% -$42.9M 0.08% 110
2024
Q2
$157M Buy
2,039,644
+820,324
+67% +$63.2M 0.1% 84
2024
Q1
$83.5M Sell
1,219,320
-8,513
-0.7% -$583K 0.06% 141
2023
Q4
$71M Buy
1,227,833
+15,596
+1% +$902K 0.05% 147
2023
Q3
$64M Buy
1,212,237
+107,093
+10% +$5.65M 0.05% 151
2023
Q2
$59.8M Buy
1,105,144
+23,098
+2% +$1.25M 0.05% 166
2023
Q1
$54.1M Buy
+1,082,046
New +$54.1M 0.05% 174
2021
Q2
Sell
-801,037
Closed -$31M 676
2021
Q1
$31M Sell
801,037
-1,047,114
-57% -$40.5M 0.02% 295
2020
Q4
$66.4M Sell
1,848,151
-5,483,346
-75% -$197M 0.05% 164
2020
Q3
$280M Sell
7,331,497
-1,650,753
-18% -$63.1M 0.23% 56
2020
Q2
$315M Sell
8,982,250
-8,085,569
-47% -$284M 0.29% 51
2020
Q1
$557M Buy
17,067,819
+5,709,360
+50% +$186M 0.68% 36
2019
Q4
$514M Buy
11,358,459
+9,545,336
+526% +$432M 0.52% 46
2019
Q3
$73.8M Sell
1,813,123
-177,487
-9% -$7.22M 0.08% 147
2019
Q2
$85.6M Sell
1,990,610
-11,204
-0.6% -$482K 0.08% 134
2019
Q1
$76.8M Buy
2,001,814
+376
+0% +$14.4K 0.08% 151
2018
Q4
$70.7M Buy
2,001,438
+1,934
+0.1% +$68.3K 0.08% 154
2018
Q3
$77M Buy
1,999,504
+16,121
+0.8% +$621K 0.07% 185
2018
Q2
$64.9M Buy
1,983,383
+35,833
+2% +$1.17M 0.06% 223
2018
Q1
$53.2M Buy
1,947,550
+210,832
+12% +$5.76M 0.05% 247
2017
Q4
$43.1M Sell
1,736,718
-6,443,302
-79% -$160M 0.04% 281
2017
Q3
$239M Sell
8,180,020
-2,459,270
-23% -$71.7M 0.24% 61
2017
Q2
$295M Buy
10,639,290
+8,533,655
+405% +$237M 0.31% 53
2017
Q1
$52.4M Buy
2,105,635
+317,319
+18% +$7.89M 0.06% 254
2016
Q4
$38.7M Buy
+1,788,316
New +$38.7M 0.04% 308